What Researchers Did
Researchers explored the usefulness of subjective measures, specifically the General Health Questionnaire (GHQ) and Nottingham Health Profile (NHP), in a controlled trial of hyperbaric oxygen therapy (HBO) for multiple sclerosis (MS).
What They Found
The study found that neither the General Health Questionnaire nor the Nottingham Health Profile appeared sensitive to the specific kinds of significance involved in assessing reported benefit. However, the Nottingham Health Profile showed potential for identifying levels of effectiveness not captured by other common measures of perceived improvement.
What This Means for Canadian Patients
This research suggests that standard subjective questionnaires may not fully capture the nuanced benefits reported by patients with multiple sclerosis undergoing treatments like hyperbaric oxygen therapy. For Canadian patients, this highlights the ongoing challenge in clinical trials to accurately assess and validate their lived experiences and perceived improvements.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
A limitation of the study was that the investigated subjective measures did not appear sensitive enough to fully capture the significance of reported patient benefits.